Janusz Skierski - Concepedia

Author

Janusz Skierski

Also Known As

J S Skierski, J Skierski, J. Skierski, J.S. Skierski, JANUSZ SKIERSKI, Janusz S Skierski, Janusz S. Skierski, Janusz Skierski, Janusz Stefan Skierski

Publications

Citations

H-Index

Concepts

All Affiliations

Instytut Farmaceutyczny Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy Warsaw University of Life Sciences Medical University of Warsaw

About

Janusz Skierski is an author at Instytut Farmaceutyczny specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	30	1.6K
2	Natural Sciences	5	5	229
3	Biochemistry	3	3	195
4	Engineering	1	1	36
5	Health Sciences	1	1	18

Janusz Skierski

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Cell cycle-specific effects of lovastatin. Marek Jakóbisiak, Silvia Bruno, Janusz Skierski, Proceedings of the National Academy of Sciences Cell ProliferationCell CycleCellular PhysiologyOxidative StressGenitourinary Cancer	1991	294
A Novel Apoptosis-like Pathway, Independent of Mitochondria and Caspases, Induced by Curcumin in Human Lymphoblastoid T (Jurkat) Cells Katarzyna Piwocka, Krzysztof Zabłocki, Mariusz R. Wiȩckowski, Experimental Cell Research InflammationMitochondrial FunctionNovel Apoptosis-like PathwayMedicineLipid Peroxidation	1999	132
Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes. Silvia Bruno, Barbara Ardelt, Janusz Skierski, PubMed ImmunologyCell ProliferationCell CycleCellular PhysiologyNuclear Membrane	1992	115
In vitro toxicity evaluation in the development of new anticancer drugs—genistein glycosides Joanna Popiołkiewicz, Krzysztof Polkowski, Janusz Skierski, Cancer Letters Pharmaceutical ScienceMedicineToxicologyAnti-cancer AgentDrug Development	2005	114
Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells. G. Del Bino, Janusz Skierski, Zbigniew Darżynkiewicz PubMed Mixed-phenotype Acute LeukemiaImmunologyCell DeathImmunophenotypingCell Cycle	1990	92
Effect of glutathione depletion on caspase-3 independent apoptosis pathway induced by curcumin in Jurkat cells Katarzyna Piwocka, Ewa Jaruga, Janusz Skierski, Free Radical Biology and Medicine InflammationChemoprevention StrategyMedicineGlutathione DepletionApoptosis	2001	82
Cytostatic and cytotoxic activity of synthetic genistein glycosides against human cancer cell lines Krzysztof Polkowski, Joanna Popiołkiewicz, Piotr Krzeczyński, Cancer Letters PhytoalexinSynthetic Genistein GlycosidesMedicineGlycobiologyAnti-cancer Agent	2003	80
Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: Relation to drug cytotoxicity and caspase-3 activation Aneta Koceva‐Chyła, Małgorzata Jędrzejczak, Janusz Skierski, APOPTOSIS Medicinal ChemistryOncologyDrug CytotoxicityMedicineApoptosis	2005	77
Expression of bcl-2 and bax in TGF-β1-induced apoptosis of L1210 leukemic cells T. Motyl, K. Grzelkowska, W. Zimowska, European Journal of Cell Biology Hematological MalignancyApoptosisImmune RegulationImmunologyCell Death	1998	61
Vibrational study of alkaline metal nicotinates, benzoates and salicylates W. Lewandowski, B Dasiewicz, Piotr Koczoń, Journal of Molecular Structure Molecular SpectroscopyPhysicochemical AnalysisAlkaline Metal NicotinatesOrganic ChemistryChemistry	2002	59

Page 1